nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0864	0.125	CbGbCtD
Arsenic trioxide—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0759	0.11	CbGbCtD
Arsenic trioxide—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0759	0.11	CbGbCtD
Arsenic trioxide—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0563	0.0813	CbGbCtD
Arsenic trioxide—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0361	0.0521	CbGbCtD
Arsenic trioxide—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0326	0.0471	CbGbCtD
Arsenic trioxide—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0282	0.0407	CbGbCtD
Arsenic trioxide—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0274	0.0395	CbGbCtD
Arsenic trioxide—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0247	0.0357	CbGbCtD
Arsenic trioxide—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0247	0.0357	CbGbCtD
Arsenic trioxide—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0237	0.0342	CbGbCtD
Arsenic trioxide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.023	0.0332	CbGbCtD
Arsenic trioxide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0216	0.0312	CbGbCtD
Arsenic trioxide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0216	0.0312	CbGbCtD
Arsenic trioxide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0196	0.0282	CbGbCtD
Arsenic trioxide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0196	0.0282	CbGbCtD
Arsenic trioxide—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0183	0.0265	CbGbCtD
Arsenic trioxide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0169	0.0244	CbGbCtD
Arsenic trioxide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0164	0.0237	CbGbCtD
Arsenic trioxide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0148	0.0214	CbGbCtD
Arsenic trioxide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0148	0.0214	CbGbCtD
Arsenic trioxide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0142	0.0205	CbGbCtD
Arsenic trioxide—AKT1—nerve—acquired immunodeficiency syndrome	0.0044	0.0291	CbGeAlD
Arsenic trioxide—MAPK1—blood plasma—acquired immunodeficiency syndrome	0.00399	0.0264	CbGeAlD
Arsenic trioxide—MAPK3—endothelium—acquired immunodeficiency syndrome	0.00397	0.0263	CbGeAlD
Arsenic trioxide—JUN—nerve—acquired immunodeficiency syndrome	0.00383	0.0253	CbGeAlD
Arsenic trioxide—AKT1—endothelium—acquired immunodeficiency syndrome	0.00375	0.0248	CbGeAlD
Arsenic trioxide—MAPK3—blood plasma—acquired immunodeficiency syndrome	0.00353	0.0233	CbGeAlD
Arsenic trioxide—AKT1—blood plasma—acquired immunodeficiency syndrome	0.00333	0.022	CbGeAlD
Arsenic trioxide—JUN—endothelium—acquired immunodeficiency syndrome	0.00326	0.0216	CbGeAlD
Arsenic trioxide—CCND1—retina—acquired immunodeficiency syndrome	0.00259	0.0171	CbGeAlD
Arsenic trioxide—CCND1—skin of body—acquired immunodeficiency syndrome	0.00228	0.0151	CbGeAlD
Arsenic trioxide—TXNRD1—retina—acquired immunodeficiency syndrome	0.00203	0.0134	CbGeAlD
Arsenic trioxide—MAPK3—retina—acquired immunodeficiency syndrome	0.00193	0.0128	CbGeAlD
Arsenic trioxide—MAPK1—skin of body—acquired immunodeficiency syndrome	0.00192	0.0127	CbGeAlD
Arsenic trioxide—CCND1—lymphoid tissue—acquired immunodeficiency syndrome	0.00184	0.0122	CbGeAlD
Arsenic trioxide—AKT1—retina—acquired immunodeficiency syndrome	0.00182	0.0121	CbGeAlD
Arsenic trioxide—CCND1—digestive system—acquired immunodeficiency syndrome	0.00182	0.012	CbGeAlD
Arsenic trioxide—TXNRD1—skin of body—acquired immunodeficiency syndrome	0.00178	0.0118	CbGeAlD
Arsenic trioxide—CCND1—blood—acquired immunodeficiency syndrome	0.00173	0.0115	CbGeAlD
Arsenic trioxide—MAPK3—skin of body—acquired immunodeficiency syndrome	0.0017	0.0112	CbGeAlD
Arsenic trioxide—CCND1—spinal cord—acquired immunodeficiency syndrome	0.00167	0.0111	CbGeAlD
Arsenic trioxide—CCND1—vagina—acquired immunodeficiency syndrome	0.00161	0.0106	CbGeAlD
Arsenic trioxide—AKT1—skin of body—acquired immunodeficiency syndrome	0.0016	0.0106	CbGeAlD
Arsenic trioxide—JUN—retina—acquired immunodeficiency syndrome	0.00159	0.0105	CbGeAlD
Arsenic trioxide—MAPK1—lymphoid tissue—acquired immunodeficiency syndrome	0.00155	0.0103	CbGeAlD
Arsenic trioxide—MAPK1—digestive system—acquired immunodeficiency syndrome	0.00153	0.0101	CbGeAlD
Arsenic trioxide—CCND1—lung—acquired immunodeficiency syndrome	0.00152	0.0101	CbGeAlD
Arsenic trioxide—MAPK1—blood—acquired immunodeficiency syndrome	0.00146	0.00966	CbGeAlD
Arsenic trioxide—TXNRD1—lymphoid tissue—acquired immunodeficiency syndrome	0.00145	0.00956	CbGeAlD
Arsenic trioxide—TXNRD1—digestive system—acquired immunodeficiency syndrome	0.00143	0.00944	CbGeAlD
Arsenic trioxide—MAPK1—bone marrow—acquired immunodeficiency syndrome	0.00141	0.00935	CbGeAlD
Arsenic trioxide—MAPK1—spinal cord—acquired immunodeficiency syndrome	0.00141	0.00931	CbGeAlD
Arsenic trioxide—CCND1—nervous system—acquired immunodeficiency syndrome	0.00141	0.00931	CbGeAlD
Arsenic trioxide—JUN—skin of body—acquired immunodeficiency syndrome	0.00139	0.00921	CbGeAlD
Arsenic trioxide—IKBKB—skin of body—acquired immunodeficiency syndrome	0.00139	0.00917	CbGeAlD
Arsenic trioxide—MAPK3—lymphoid tissue—acquired immunodeficiency syndrome	0.00137	0.00909	CbGeAlD
Arsenic trioxide—TXNRD1—blood—acquired immunodeficiency syndrome	0.00136	0.009	CbGeAlD
Arsenic trioxide—MAPK3—digestive system—acquired immunodeficiency syndrome	0.00136	0.00898	CbGeAlD
Arsenic trioxide—CCND1—central nervous system—acquired immunodeficiency syndrome	0.00136	0.00896	CbGeAlD
Arsenic trioxide—MAPK1—vagina—acquired immunodeficiency syndrome	0.00135	0.00896	CbGeAlD
Arsenic trioxide—TXNRD1—bone marrow—acquired immunodeficiency syndrome	0.00132	0.0087	CbGeAlD
Arsenic trioxide—TXNRD1—spinal cord—acquired immunodeficiency syndrome	0.00131	0.00867	CbGeAlD
Arsenic trioxide—AKT1—lymphoid tissue—acquired immunodeficiency syndrome	0.0013	0.00857	CbGeAlD
Arsenic trioxide—MAPK3—blood—acquired immunodeficiency syndrome	0.00129	0.00855	CbGeAlD
Arsenic trioxide—MAPK1—lung—acquired immunodeficiency syndrome	0.00128	0.00847	CbGeAlD
Arsenic trioxide—AKT1—digestive system—acquired immunodeficiency syndrome	0.00128	0.00847	CbGeAlD
Arsenic trioxide—TXNRD1—vagina—acquired immunodeficiency syndrome	0.00126	0.00834	CbGeAlD
Arsenic trioxide—MAPK3—bone marrow—acquired immunodeficiency syndrome	0.00125	0.00828	CbGeAlD
Arsenic trioxide—MAPK3—spinal cord—acquired immunodeficiency syndrome	0.00125	0.00824	CbGeAlD
Arsenic trioxide—AKT1—blood—acquired immunodeficiency syndrome	0.00122	0.00807	CbGeAlD
Arsenic trioxide—MAPK3—vagina—acquired immunodeficiency syndrome	0.0012	0.00793	CbGeAlD
Arsenic trioxide—TXNRD1—lung—acquired immunodeficiency syndrome	0.00119	0.00789	CbGeAlD
Arsenic trioxide—MAPK1—nervous system—acquired immunodeficiency syndrome	0.00119	0.00785	CbGeAlD
Arsenic trioxide—AKT1—bone marrow—acquired immunodeficiency syndrome	0.00118	0.0078	CbGeAlD
Arsenic trioxide—AKT1—spinal cord—acquired immunodeficiency syndrome	0.00117	0.00777	CbGeAlD
Arsenic trioxide—MAPK1—central nervous system—acquired immunodeficiency syndrome	0.00114	0.00755	CbGeAlD
Arsenic trioxide—MAPK3—lung—acquired immunodeficiency syndrome	0.00113	0.0075	CbGeAlD
Arsenic trioxide—AKT1—vagina—acquired immunodeficiency syndrome	0.00113	0.00748	CbGeAlD
Arsenic trioxide—JUN—lymphoid tissue—acquired immunodeficiency syndrome	0.00113	0.00746	CbGeAlD
Arsenic trioxide—IKBKB—lymphoid tissue—acquired immunodeficiency syndrome	0.00112	0.00743	CbGeAlD
Arsenic trioxide—JUN—digestive system—acquired immunodeficiency syndrome	0.00111	0.00737	CbGeAlD
Arsenic trioxide—IKBKB—digestive system—acquired immunodeficiency syndrome	0.00111	0.00733	CbGeAlD
Arsenic trioxide—TXNRD1—nervous system—acquired immunodeficiency syndrome	0.0011	0.0073	CbGeAlD
Arsenic trioxide—CCND1—brain—acquired immunodeficiency syndrome	0.00108	0.00712	CbGeAlD
Arsenic trioxide—AKT1—lung—acquired immunodeficiency syndrome	0.00107	0.00707	CbGeAlD
Arsenic trioxide—TXNRD1—central nervous system—acquired immunodeficiency syndrome	0.00106	0.00703	CbGeAlD
Arsenic trioxide—JUN—blood—acquired immunodeficiency syndrome	0.00106	0.00702	CbGeAlD
Arsenic trioxide—IKBKB—blood—acquired immunodeficiency syndrome	0.00106	0.00699	CbGeAlD
Arsenic trioxide—MAPK3—nervous system—acquired immunodeficiency syndrome	0.00105	0.00694	CbGeAlD
Arsenic trioxide—CCND1—lymph node—acquired immunodeficiency syndrome	0.00104	0.00688	CbGeAlD
Arsenic trioxide—JUN—bone marrow—acquired immunodeficiency syndrome	0.00103	0.00679	CbGeAlD
Arsenic trioxide—JUN—spinal cord—acquired immunodeficiency syndrome	0.00102	0.00676	CbGeAlD
Arsenic trioxide—MAPK3—central nervous system—acquired immunodeficiency syndrome	0.00101	0.00669	CbGeAlD
Arsenic trioxide—AKT1—nervous system—acquired immunodeficiency syndrome	0.00099	0.00655	CbGeAlD
Arsenic trioxide—JUN—vagina—acquired immunodeficiency syndrome	0.000984	0.00651	CbGeAlD
Arsenic trioxide—IKBKB—vagina—acquired immunodeficiency syndrome	0.000979	0.00648	CbGeAlD
Arsenic trioxide—AKT1—central nervous system—acquired immunodeficiency syndrome	0.000953	0.0063	CbGeAlD
Arsenic trioxide—JUN—lung—acquired immunodeficiency syndrome	0.00093	0.00615	CbGeAlD
Arsenic trioxide—IKBKB—lung—acquired immunodeficiency syndrome	0.000926	0.00613	CbGeAlD
Arsenic trioxide—MAPK1—brain—acquired immunodeficiency syndrome	0.000907	0.006	CbGeAlD
Arsenic trioxide—MAPK1—lymph node—acquired immunodeficiency syndrome	0.000876	0.00579	CbGeAlD
Arsenic trioxide—JUN—nervous system—acquired immunodeficiency syndrome	0.000862	0.0057	CbGeAlD
Arsenic trioxide—IKBKB—nervous system—acquired immunodeficiency syndrome	0.000858	0.00567	CbGeAlD
Arsenic trioxide—TXNRD1—brain—acquired immunodeficiency syndrome	0.000844	0.00558	CbGeAlD
Arsenic trioxide—JUN—central nervous system—acquired immunodeficiency syndrome	0.00083	0.00549	CbGeAlD
Arsenic trioxide—IKBKB—central nervous system—acquired immunodeficiency syndrome	0.000826	0.00546	CbGeAlD
Arsenic trioxide—TXNRD1—lymph node—acquired immunodeficiency syndrome	0.000815	0.00539	CbGeAlD
Arsenic trioxide—MAPK3—brain—acquired immunodeficiency syndrome	0.000802	0.00531	CbGeAlD
Arsenic trioxide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000801	0.0053	CbGeAlD
Arsenic trioxide—MAPK3—lymph node—acquired immunodeficiency syndrome	0.000775	0.00513	CbGeAlD
Arsenic trioxide—AKT1—brain—acquired immunodeficiency syndrome	0.000757	0.00501	CbGeAlD
Arsenic trioxide—CYP1B1—skin of body—acquired immunodeficiency syndrome	0.000743	0.00491	CbGeAlD
Arsenic trioxide—AKT1—lymph node—acquired immunodeficiency syndrome	0.000731	0.00484	CbGeAlD
Arsenic trioxide—JUN—brain—acquired immunodeficiency syndrome	0.000659	0.00436	CbGeAlD
Arsenic trioxide—IKBKB—brain—acquired immunodeficiency syndrome	0.000655	0.00434	CbGeAlD
Arsenic trioxide—JUN—lymph node—acquired immunodeficiency syndrome	0.000636	0.00421	CbGeAlD
Arsenic trioxide—IKBKB—lymph node—acquired immunodeficiency syndrome	0.000633	0.00419	CbGeAlD
Arsenic trioxide—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000606	0.00401	CbGeAlD
Arsenic trioxide—CYP1B1—lymphoid tissue—acquired immunodeficiency syndrome	0.000601	0.00398	CbGeAlD
Arsenic trioxide—CYP1B1—digestive system—acquired immunodeficiency syndrome	0.000594	0.00393	CbGeAlD
Arsenic trioxide—ABCC2—blood—acquired immunodeficiency syndrome	0.000578	0.00382	CbGeAlD
Arsenic trioxide—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000567	0.00375	CbGeAlD
Arsenic trioxide—CYP1B1—blood—acquired immunodeficiency syndrome	0.000566	0.00374	CbGeAlD
Arsenic trioxide—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000525	0.00347	CbGeAlD
Arsenic trioxide—CYP1B1—lung—acquired immunodeficiency syndrome	0.000496	0.00328	CbGeAlD
Arsenic trioxide—CYP1B1—nervous system—acquired immunodeficiency syndrome	0.000459	0.00304	CbGeAlD
Arsenic trioxide—CYP1B1—central nervous system—acquired immunodeficiency syndrome	0.000442	0.00293	CbGeAlD
Arsenic trioxide—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.00042	0.00278	CbGeAlD
Arsenic trioxide—CYP1A1—blood—acquired immunodeficiency syndrome	0.0004	0.00265	CbGeAlD
Arsenic trioxide—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000371	0.00245	CbGeAlD
Arsenic trioxide—CYP1B1—brain—acquired immunodeficiency syndrome	0.000351	0.00232	CbGeAlD
Arsenic trioxide—CYP1A1—lung—acquired immunodeficiency syndrome	0.000351	0.00232	CbGeAlD
Arsenic trioxide—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000346	0.00229	CbGeAlD
Arsenic trioxide—CYP1B1—lymph node—acquired immunodeficiency syndrome	0.000339	0.00224	CbGeAlD
Arsenic trioxide—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000325	0.00215	CbGeAlD
Arsenic trioxide—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000313	0.00207	CbGeAlD
Arsenic trioxide—ABCB1—retina—acquired immunodeficiency syndrome	0.000311	0.00205	CbGeAlD
Arsenic trioxide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000308	0.00204	CbGeAlD
Arsenic trioxide—CYP3A4—blood—acquired immunodeficiency syndrome	0.000294	0.00194	CbGeAlD
Arsenic trioxide—CYP1A1—brain—acquired immunodeficiency syndrome	0.000248	0.00164	CbGeAlD
Arsenic trioxide—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.00024	0.00159	CbGeAlD
Arsenic trioxide—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000238	0.00158	CbGeAlD
Arsenic trioxide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000229	0.00152	CbGeAlD
Arsenic trioxide—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000221	0.00146	CbGeAlD
Arsenic trioxide—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000218	0.00144	CbGeAlD
Arsenic trioxide—ABCB1—blood—acquired immunodeficiency syndrome	0.000208	0.00137	CbGeAlD
Arsenic trioxide—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000201	0.00133	CbGeAlD
Arsenic trioxide—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.0002	0.00132	CbGeAlD
Arsenic trioxide—ABCB1—vagina—acquired immunodeficiency syndrome	0.000193	0.00127	CbGeAlD
Arsenic trioxide—ABCB1—lung—acquired immunodeficiency syndrome	0.000182	0.0012	CbGeAlD
Arsenic trioxide—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000169	0.00112	CbGeAlD
Arsenic trioxide—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000162	0.00107	CbGeAlD
Arsenic trioxide—ABCB1—brain—acquired immunodeficiency syndrome	0.000129	0.000853	CbGeAlD
Arsenic trioxide—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000125	0.000824	CbGeAlD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	5.37e-05	0.000344	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	5.35e-05	0.000343	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	5.35e-05	0.000343	CbGpPWpGaD
Arsenic trioxide—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	5.34e-05	0.000342	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—ALB—acquired immunodeficiency syndrome	5.34e-05	0.000342	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	5.33e-05	0.000341	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.31e-05	0.00034	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.31e-05	0.00034	CbGpPWpGaD
Arsenic trioxide—AKT1—DAP12 signaling—IL6—acquired immunodeficiency syndrome	5.3e-05	0.000339	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	5.3e-05	0.000339	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	5.29e-05	0.000339	CbGpPWpGaD
Arsenic trioxide—MAPK1—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	5.28e-05	0.000338	CbGpPWpGaD
Arsenic trioxide—IKBKB—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	5.28e-05	0.000338	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	5.27e-05	0.000337	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	5.27e-05	0.000337	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.24e-05	0.000335	CbGpPWpGaD
Arsenic trioxide—MAPK3—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	5.22e-05	0.000334	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.21e-05	0.000334	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	5.2e-05	0.000333	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.2e-05	0.000333	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	5.19e-05	0.000332	CbGpPWpGaD
Arsenic trioxide—JUN—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	5.19e-05	0.000332	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	5.19e-05	0.000332	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	5.17e-05	0.000331	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CCR2—acquired immunodeficiency syndrome	5.16e-05	0.00033	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.15e-05	0.00033	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.15e-05	0.00033	CbGpPWpGaD
Arsenic trioxide—MAPK3—DAP12 signaling—IL6—acquired immunodeficiency syndrome	5.14e-05	0.000329	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.12e-05	0.000328	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	5.09e-05	0.000326	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CCR2—acquired immunodeficiency syndrome	5e-05	0.00032	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular Senescence—IL6—acquired immunodeficiency syndrome	4.99e-05	0.000319	CbGpPWpGaD
Arsenic trioxide—AKT1—DAP12 interactions—IL6—acquired immunodeficiency syndrome	4.99e-05	0.000319	CbGpPWpGaD
Arsenic trioxide—AKT1—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	4.99e-05	0.000319	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	4.99e-05	0.000319	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.98e-05	0.000319	CbGpPWpGaD
Arsenic trioxide—MAPK1—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	4.97e-05	0.000318	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	4.94e-05	0.000317	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	4.94e-05	0.000316	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	4.92e-05	0.000315	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	4.9e-05	0.000314	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.9e-05	0.000314	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.9e-05	0.000314	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 signaling—IL6—acquired immunodeficiency syndrome	4.89e-05	0.000313	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	4.88e-05	0.000312	CbGpPWpGaD
Arsenic trioxide—MAPK3—DAP12 interactions—IL6—acquired immunodeficiency syndrome	4.84e-05	0.00031	CbGpPWpGaD
Arsenic trioxide—MAPK3—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	4.84e-05	0.00031	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	4.84e-05	0.00031	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IFNA1—acquired immunodeficiency syndrome	4.83e-05	0.000309	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	4.82e-05	0.000309	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	4.8e-05	0.000307	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.77e-05	0.000305	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CCR2—acquired immunodeficiency syndrome	4.76e-05	0.000305	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	4.75e-05	0.000304	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	4.73e-05	0.000303	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD79A—acquired immunodeficiency syndrome	4.69e-05	0.0003	CbGpPWpGaD
Arsenic trioxide—JUN—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	4.69e-05	0.0003	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.68e-05	0.0003	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular Senescence—IL6—acquired immunodeficiency syndrome	4.65e-05	0.000298	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IFNA1—acquired immunodeficiency syndrome	4.64e-05	0.000297	CbGpPWpGaD
Arsenic trioxide—MAPK1—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	4.6e-05	0.000295	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 interactions—IL6—acquired immunodeficiency syndrome	4.6e-05	0.000295	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	4.6e-05	0.000295	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.57e-05	0.000293	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	4.56e-05	0.000292	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CCR2—acquired immunodeficiency syndrome	4.55e-05	0.000292	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	4.52e-05	0.00029	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—ALB—acquired immunodeficiency syndrome	4.52e-05	0.000289	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD79A—acquired immunodeficiency syndrome	4.51e-05	0.000289	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IFNA1—acquired immunodeficiency syndrome	4.5e-05	0.000288	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	4.5e-05	0.000288	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CXCR4—acquired immunodeficiency syndrome	4.48e-05	0.000287	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.45e-05	0.000285	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular Senescence—IL6—acquired immunodeficiency syndrome	4.42e-05	0.000283	CbGpPWpGaD
Arsenic trioxide—AKT1—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	4.42e-05	0.000283	CbGpPWpGaD
Arsenic trioxide—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	4.4e-05	0.000282	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—ALB—acquired immunodeficiency syndrome	4.38e-05	0.00028	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.38e-05	0.00028	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD79A—acquired immunodeficiency syndrome	4.37e-05	0.00028	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CXCR4—acquired immunodeficiency syndrome	4.34e-05	0.000278	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	4.29e-05	0.000275	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IFNA1—acquired immunodeficiency syndrome	4.29e-05	0.000274	CbGpPWpGaD
Arsenic trioxide—MAPK3—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	4.29e-05	0.000274	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—ALB—acquired immunodeficiency syndrome	4.17e-05	0.000267	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD79A—acquired immunodeficiency syndrome	4.16e-05	0.000266	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	4.14e-05	0.000265	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CXCR4—acquired immunodeficiency syndrome	4.13e-05	0.000265	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IFNA1—acquired immunodeficiency syndrome	4.1e-05	0.000263	CbGpPWpGaD
Arsenic trioxide—MAPK1—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	4.08e-05	0.000261	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.04e-05	0.000259	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.01e-05	0.000256	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD79A—acquired immunodeficiency syndrome	3.98e-05	0.000255	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.98e-05	0.000255	CbGpPWpGaD
Arsenic trioxide—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.94e-05	0.000252	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.92e-05	0.000251	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.86e-05	0.000247	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.84e-05	0.000246	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD40LG—acquired immunodeficiency syndrome	3.83e-05	0.000245	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD8A—acquired immunodeficiency syndrome	3.78e-05	0.000242	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CSF2—acquired immunodeficiency syndrome	3.78e-05	0.000242	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	3.77e-05	0.000241	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—CD4—acquired immunodeficiency syndrome	3.73e-05	0.000239	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.73e-05	0.000239	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.69e-05	0.000236	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD40LG—acquired immunodeficiency syndrome	3.68e-05	0.000235	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.67e-05	0.000235	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—IL2—acquired immunodeficiency syndrome	3.66e-05	0.000234	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.65e-05	0.000234	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HLA-B—acquired immunodeficiency syndrome	3.64e-05	0.000233	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.64e-05	0.000233	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CSF2—acquired immunodeficiency syndrome	3.63e-05	0.000233	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD8A—acquired immunodeficiency syndrome	3.63e-05	0.000233	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CD4—acquired immunodeficiency syndrome	3.58e-05	0.000229	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.58e-05	0.000229	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD40LG—acquired immunodeficiency syndrome	3.57e-05	0.000228	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—IL2—acquired immunodeficiency syndrome	3.55e-05	0.000227	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.53e-05	0.000226	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD8A—acquired immunodeficiency syndrome	3.53e-05	0.000226	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CSF2—acquired immunodeficiency syndrome	3.53e-05	0.000226	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	3.51e-05	0.000225	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HLA-B—acquired immunodeficiency syndrome	3.5e-05	0.000224	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CD4—acquired immunodeficiency syndrome	3.48e-05	0.000223	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.47e-05	0.000222	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	3.44e-05	0.00022	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.42e-05	0.000219	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.4e-05	0.000218	CbGpPWpGaD
Arsenic trioxide—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.4e-05	0.000218	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	3.4e-05	0.000218	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD40LG—acquired immunodeficiency syndrome	3.39e-05	0.000217	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HLA-B—acquired immunodeficiency syndrome	3.39e-05	0.000217	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—IL2—acquired immunodeficiency syndrome	3.38e-05	0.000216	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.36e-05	0.000215	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD8A—acquired immunodeficiency syndrome	3.35e-05	0.000215	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CSF2—acquired immunodeficiency syndrome	3.35e-05	0.000215	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	3.35e-05	0.000215	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	3.34e-05	0.000214	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.34e-05	0.000214	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CD4—acquired immunodeficiency syndrome	3.31e-05	0.000212	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—IL6—acquired immunodeficiency syndrome	3.3e-05	0.000211	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.26e-05	0.000209	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.26e-05	0.000209	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.26e-05	0.000208	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD40LG—acquired immunodeficiency syndrome	3.25e-05	0.000208	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.23e-05	0.000207	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-B—acquired immunodeficiency syndrome	3.23e-05	0.000207	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CSF2—acquired immunodeficiency syndrome	3.21e-05	0.000205	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD8A—acquired immunodeficiency syndrome	3.21e-05	0.000205	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	3.19e-05	0.000204	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CD4—acquired immunodeficiency syndrome	3.16e-05	0.000203	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	3.14e-05	0.000201	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.14e-05	0.000201	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.14e-05	0.000201	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-B—acquired immunodeficiency syndrome	3.09e-05	0.000198	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.08e-05	0.000197	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CCR5—acquired immunodeficiency syndrome	3.07e-05	0.000196	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	3.05e-05	0.000195	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.04e-05	0.000195	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.04e-05	0.000195	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	3.04e-05	0.000195	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—IL6—acquired immunodeficiency syndrome	3e-05	0.000192	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—IL6—acquired immunodeficiency syndrome	2.98e-05	0.000191	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CCR5—acquired immunodeficiency syndrome	2.98e-05	0.000191	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.94e-05	0.000189	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.89e-05	0.000185	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.89e-05	0.000185	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—IL6—acquired immunodeficiency syndrome	2.84e-05	0.000182	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CCR5—acquired immunodeficiency syndrome	2.83e-05	0.000181	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.77e-05	0.000177	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.77e-05	0.000177	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TNF—acquired immunodeficiency syndrome	2.72e-05	0.000174	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.7e-05	0.000173	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.65e-05	0.000169	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TNF—acquired immunodeficiency syndrome	2.64e-05	0.000169	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TNF—acquired immunodeficiency syndrome	2.51e-05	0.000161	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.48e-05	0.000159	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.45e-05	0.000157	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.39e-05	0.000153	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	2.38e-05	0.000152	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.35e-05	0.00015	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.31e-05	0.000148	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.31e-05	0.000148	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.28e-05	0.000146	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IFNG—acquired immunodeficiency syndrome	2.25e-05	0.000144	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	2.25e-05	0.000144	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.24e-05	0.000143	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.2e-05	0.000141	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—IL6—acquired immunodeficiency syndrome	2.19e-05	0.00014	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD4—acquired immunodeficiency syndrome	2.17e-05	0.000139	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.17e-05	0.000139	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IFNG—acquired immunodeficiency syndrome	2.16e-05	0.000138	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.15e-05	0.000138	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—IL6—acquired immunodeficiency syndrome	2.13e-05	0.000136	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.11e-05	0.000135	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.11e-05	0.000135	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.1e-05	0.000135	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IFNG—acquired immunodeficiency syndrome	2.1e-05	0.000134	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD4—acquired immunodeficiency syndrome	2.09e-05	0.000134	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.08e-05	0.000133	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.07e-05	0.000133	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.04e-05	0.000131	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—IL6—acquired immunodeficiency syndrome	2.03e-05	0.00013	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD4—acquired immunodeficiency syndrome	2.02e-05	0.00013	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—IL6—acquired immunodeficiency syndrome	2.02e-05	0.000129	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL2—acquired immunodeficiency syndrome	2e-05	0.000128	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IFNG—acquired immunodeficiency syndrome	1.99e-05	0.000128	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.98e-05	0.000127	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.94e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.94e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CD4—acquired immunodeficiency syndrome	1.93e-05	0.000123	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD4—acquired immunodeficiency syndrome	1.93e-05	0.000123	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL2—acquired immunodeficiency syndrome	1.92e-05	0.000123	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IFNG—acquired immunodeficiency syndrome	1.91e-05	0.000122	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.9e-05	0.000121	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.88e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CD4—acquired immunodeficiency syndrome	1.87e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL2—acquired immunodeficiency syndrome	1.86e-05	0.000119	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD4—acquired immunodeficiency syndrome	1.84e-05	0.000118	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—ALB—acquired immunodeficiency syndrome	1.83e-05	0.000117	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.79e-05	0.000115	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CD4—acquired immunodeficiency syndrome	1.78e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL2—acquired immunodeficiency syndrome	1.77e-05	0.000113	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.71e-05	0.00011	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL2—acquired immunodeficiency syndrome	1.7e-05	0.000109	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.6e-05	0.000102	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.59e-05	0.000102	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ALB—acquired immunodeficiency syndrome	1.52e-05	9.75e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.29e-05	8.27e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.24e-05	7.95e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.24e-05	7.91e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.2e-05	7.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.2e-05	7.67e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL6—acquired immunodeficiency syndrome	1.18e-05	7.52e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.15e-05	7.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.14e-05	7.3e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL6—acquired immunodeficiency syndrome	1.13e-05	7.23e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.1e-05	7.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL6—acquired immunodeficiency syndrome	1.09e-05	7.01e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—IL6—acquired immunodeficiency syndrome	1.04e-05	6.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL6—acquired immunodeficiency syndrome	1.04e-05	6.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—IL6—acquired immunodeficiency syndrome	1.01e-05	6.47e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL6—acquired immunodeficiency syndrome	9.97e-06	6.38e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—IL6—acquired immunodeficiency syndrome	9.62e-06	6.16e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ALB—acquired immunodeficiency syndrome	9.38e-06	6e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.6e-06	4.86e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	7.49e-06	4.79e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.3e-06	4.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.08e-06	4.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.74e-06	4.31e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.44e-06	4.13e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	4.61e-06	2.95e-05	CbGpPWpGaD
